Prelude Capital Management’s Humana HUM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $246K | Sell |
620
-725
| -54% | -$206K | 0.02% | 881 |
|
|
2026
Q1 | $233K | Buy |
+1,345
| New | +$276K | 0.02% | 834 |
|
|
2025
Q1 | – | Sell |
-13,602
| Closed | -$3.45M | – | 1344 |
|
|
2024
Q4 | $3.45M | Buy |
13,602
+2,870
| +27% | +$770K | 0.22% | 96 |
|
|
2024
Q3 | $3.4M | Sell |
10,732
-5,229
| -33% | -$1.86M | 0.21% | 116 |
|
|
2024
Q2 | $5.96M | Sell |
15,961
-334
| -2% | -$113K | 0.41% | 48 |
|
|
2024
Q1 | $5.65M | Buy |
+16,295
| New | +$6.18M | 0.3% | 50 |
|
|
2023
Q4 | – | Sell |
-1,800
| Closed | -$876K | – | 1217 |
|
|
2023
Q3 | $876K | Buy |
1,800
+886
| +97% | +$416K | 0.06% | 330 |
|
|
2023
Q2 | $409K | Sell |
914
-405
| -31% | -$204K | 0.03% | 540 |
|
|
2023
Q1 | $640K | Sell |
1,319
-1,400
| -51% | -$692K | 0.04% | 392 |
|
|
2022
Q4 | $1.39M | Sell |
2,719
-1,391
| -34% | -$731K | 0.07% | 291 |
|
|
2022
Q3 | $1.99M | Buy |
4,110
+1,273
| +45% | +$619K | 0.07% | 233 |
|
|
2022
Q2 | $1.33M | Sell |
2,837
-390
| -12% | -$174K | 0.04% | 421 |
|
|
2022
Q1 | $1.4M | Buy |
3,227
+1,357
| +73% | +$568K | 0.04% | 471 |
|
|
2021
Q4 | $867K | Buy |
1,870
+758
| +68% | +$335K | 0.02% | 690 |
|
|
2021
Q3 | $433K | Buy |
+1,112
| New | +$472K | 0.01% | 965 |
|
|
2021
Q2 | – | Sell |
-1,533
| Closed | -$644K | – | 1782 |
|
|
2021
Q1 | $644K | Buy |
1,533
+394
| +35% | +$157K | 0.02% | 783 |
|
|
2020
Q4 | $467K | Buy |
1,139
+712
| +167% | +$296K | 0.01% | 747 |
|
|
2020
Q3 | $177K | Buy |
+427
| New | +$172K | 0.01% | 722 |
|
|
2020
Q2 | – | Sell |
-245
| Closed | -$77K | – | 2087 |
|
|
2020
Q1 | $77K | Sell |
245
-218
| -47% | -$73.5K | 0.01% | 658 |
|
|
2019
Q4 | $170K | Buy |
463
+32
| +7% | +$10.1K | 0.01% | 904 |
|
|
2019
Q3 | $110K | Buy |
+431
| New | +$121K | 0.01% | 918 |
|
|
2019
Q1 | – | Sell |
-287
| Closed | -$82K | – | 1944 |
|
|
2018
Q4 | $82K | Sell |
287
-1,033
| -78% | -$328K | 0.01% | 987 |
|
|
2018
Q3 | $447K | Buy |
1,320
+161
| +14% | +$52.3K | 0.03% | 553 |
|
|
2018
Q2 | $345K | Sell |
1,159
-90
| -7% | -$26.4K | 0.02% | 635 |
|
|
2018
Q1 | $336K | Buy |
1,249
+269
| +27% | +$72.8K | 0.02% | 548 |
|
|
2017
Q4 | $243K | Sell |
980
-94
| -9% | -$23.2K | 0.02% | 573 |
|
|
2017
Q3 | $262K | Buy |
1,074
+75
| +8% | +$18.4K | 0.02% | 563 |
|
|
2017
Q2 | $240K | Buy |
999
+72
| +8% | +$16.3K | 0.02% | 522 |
|
|
2017
Q1 | $191K | Sell |
927
-6,152
| -87% | -$1.27M | 0.02% | 579 |
|
|
2016
Q4 | $1.44M | Sell |
7,079
-5,318
| -43% | -$1.01M | 0.17% | 145 |
|
|
2016
Q3 | $2.19M | Buy |
12,397
+2,464
| +25% | +$428K | 0.23% | 88 |
|
|
2016
Q2 | $1.79M | Sell |
9,933
-2,667
| -21% | -$474K | 0.25% | 107 |
|
|
2016
Q1 | $2.31M | Buy |
12,600
+3,980
| +46% | +$690K | 0.32% | 69 |
|
|
2015
Q4 | $1.54M | Buy |
8,620
+2,320
| +37% | +$407K | 0.24% | 98 |
|
|
2015
Q3 | $1.13M | Buy |
6,300
+5,300
| +530% | +$980K | 0.16% | 147 |
|
|
2015
Q2 | $191K | Buy |
+1,000
| New | +$186K | 0.03% | 619 |
|
|
2015
Q1 | – | Sell |
-300
| Closed | -$43K | – | 2032 |
|
|
2014
Q4 | $43K | Buy |
+300
| New | +$41K | 0.01% | 1305 |
|
|
2014
Q3 | – | Sell |
-170
| Closed | -$22K | – | 1968 |
|
|
2014
Q2 | $22K | Sell |
170
-2,230
| -93% | -$264K | ﹤0.01% | 1699 |
|
|
2014
Q1 | $271K | Buy |
+2,400
| New | +$250K | 0.04% | 621 |
|
Other funds holding HUM
SC
Prelude Capital Management's HUM Position: Q2 2026 in Review
Prelude Capital Management reduced its Humana (HUM) stake by 54% in Q2 2026, selling an estimated $206K and leaving 620 shares worth $246K. The position accounts for 0.02% of the portfolio, ranked #881.
Prelude Capital Management first reported a position in HUM in Q1 2014 and has held it in 39 quarters since. The position peaked at $5.96M in Q2 2024. 923 funds tracked by Wall St. Rank hold HUM as of Q2 2026.
- Prelude Capital Management held 620 shares of Humana worth $246K as of Q2 2026.
- Prelude Capital Management sold 725 Humana shares in Q2 2026, an estimated $206K.
- Humana made up 0.02% of Prelude Capital Management's portfolio in Q2 2026, its #881 holding.
- Prelude Capital Management first reported a position in Humana in Q1 2014 and has held it in 39 quarters since.
- Prelude Capital Management's Humana position peaked at $5.96M in Q2 2024.
- 923 funds tracked by Wall St. Rank held Humana as of Q2 2026.
Based on Prelude Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.